All Stories

  1. Ultrastructural analysis of collagen fibril diameter distribution in cleft lip
  2. Association between a common missense variant in LOXL3 gene and the risk of non-syndromic cleft palate
  3. Nonsyndromic cleft palate: An association study at GWAS candidate loci in a multiethnic sample
  4. Evaluating LINE-1 methylation in cleft lip tissues and its association with early pregnancy exposures
  5. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
  6. Muscle fiber diameter assessment in cleft lip using image processing
  7. Genetic Interactions in Nonsyndromic Orofacial Clefts in Europe—EUROCRAN Study
  8. Tooth agenesis and orofacial clefting: genetic brothers in arms?
  9. Meta-analysis Reveals Genome-Wide Significance at 15q13 for Nonsyndromic Clefting of Both the Lip and the Palate, and Functional Analyses Implicate GREM1 As a Plausible Causative Gene
  10. Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts
  11. A new method of detecting changes in corneal health in response to toxic insults
  12. Generation and Characterization of a Transgenic Mouse Carrying a Functional Humanβ-Globin Gene with the IVSI-6 Thalassemia Mutation
  13. Strong Association of Variants around FOXE1 and Orofacial Clefting
  14. Genome-wide analysis of parent-of-origin effects in non-syndromic orofacial clefts
  15. Analysis of susceptibility loci for nonsyndromic orofacial clefting in a European trio sample
  16. Confirming genes influencing risk to cleft lip with/without cleft palate in a case–parent trio study
  17. Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic Landmarks
  18. Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci
  19. FAF1, a Gene that Is Disrupted in Cleft Palate and Has Conserved Function in Zebrafish
  20. Co-expression of matrix metalloproteinase-7 (MMP-7) and phosphorylated insulin growth factor receptor I (pIGF-1R) correlates with poor prognosis in patients with wild-type KRAS treated with cetuximab or panitumumab: A GEMCAD study
  21. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate
  22. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24
  23. P2X7gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus
  24. Disruption of an AP-2α binding site in an IRF6 enhancer is associated with cleft lip
  25. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus
  26. Exclusion of COL2A1 and VDR as Developmental Dysplasia of the Hip Genes
  27. Colorectal cancer screening: Results of a 5-year program in asymptomatic subjects at increased risk
  28. HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis
  29. Development of strategies for the use of anti-growth factor treatments
  30. Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer
  31. Cystathionine beta-synthase c.844ins68 gene variant and non-syndromic cleft lip and palate
  32. Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells
  33. Epidemiology of Cleft Palate in Europe: Implications for Genetic Research
  34. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas
  35. Screening colonoscopy in asymptomatic increased-risk subjects
  36. Characterization of an Antibody That Can Detect an Activated IGF-I Receptor in Human Cancers
  37. PROTOANEMONIN-INDUCED CYTOTOXIC EFFECTS INEUGLENA GRACILIS
  38. The IGF-I receptor in cell growth, transformation and apoptosis
  39. Identification of Signalling Components in Tyrosine Kinase Cascades Using Phosphopeptide Affinity Chromatography
  40. The IGF-I Receptor in Mitogenesis and Transformation of Mouse Embryo Cells: Role of Receptor Number
  41. RAPD analysis of systematic relationships among the Cervidae
  42. Platelet-Derived Growth Factor Increases the Activity of the Promoter of the Insulin-like Growth Factor-1 (IGF-1) Receptor Gene
  43. The role of the IGF-I receptor in the growth and transformation of mammalian cells
  44. Heteromorphic Variant 18ph+ Analyzed by Sequential CBG and Fluorescence in situ Hybridization
  45. Cytological Characterization of a Giant Strain ofEuglena gracilisObtained from Dark-starved Cultures
  46. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.
  47. Identification of a novel protein kinase C inhibitor in microsomes from phytohaemagglutinin activated human peripheral blood mononuclear cells
  48. Anchored anti-HLA class I monoclonal antibody fails to induce inhibition of PHA- activated lymphocytes proliferation
  49. Altered proliferative kinetics in PHA-activated human T-lymphocytes treated with the anti-HLA class I monoclonal antibody 01.65
  50. High-resolution G-banded karyotype ofCervus elaphus corsicanus, Erxleben
  51. An anti-HLA class I monoclonal antibody alters the progression in the cell cycle of phytohemagglutinin-activated human T lymphocytes
  52. Chromosomal evolution in cervidae
  53. Anti HLA class I monoclonal antibody effect on PKC kinetics in PHA activated human peripheral blood mononuclear and E 4 cells
  54. Cytogenetic Studies onCervus ElaphusL. Constitutive Heterochromatin and Nucleolus Organizer Regions